Appili Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
#21-1344 Summer St, Halifax, Nova Scotia...Phone Number
(902) 442-4655Website
www.appilitherapeutics.comRevenue
<$5 MillionStock Symbol
APLIIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Appili Therapeutics
Appili Therapeutics is a biopharmaceutical company dedicated to addressing global challenges in infectious diseases and biodefense. The company focuses on innovative drug development programs aimed at meeting unmet patient needs across a variety of infectious diseases. Their product pipeline includes a novel oral suspension for serious infections, a potential vaccine for tularemia, and a topical treatment for skin infections. Appili Therapeutics actively seeks partnerships to enhance clinical programs and accelerate the commercialization of their solutions.Explore more
Appili Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Appili Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Appili Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Appili Therapeutics has new funding data
Appili Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Appili Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Appili Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Appili Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Appili Therapeutics recently announced quarterly report
Product Launch: Get notified when Appili Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Appili Therapeutics
Compare insights from companies similar to Appili Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Appili Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Appili Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Appili Therapeutics.
Appili Therapeutics financials insights
Gather financial insights about Appili Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$3.3M
Share Placement
$2.2M
2017
Grant
$2.8M
Share Placement
$3.1M
2018
Private Equity
$4.3M
2021
Debt
$3.5M
Debt
$4.1M
2022
Other Financing Round
$10M
Other Financing Round
$14M
2023
Debt
$1.8M
2024
Other Financing Round
$300K
Appili Therapeutics Tech Stack
A closer look at the technologies used by Appili Therapeutics
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Project
Product Management, Intellectual Property, Legal Affairs
Executive Move
Board of Directors
Appili Therapeutics News & Media
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1Appili Therapeutics to Exhibit at World Vaccine Congress Washington
Appili Presentation Highlights Recent Collaborations and Funding MilestonesAppili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICESAppili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Appili Therapeutics
Sign Up For FreeTo access detailed company insights
Appili Therapeutics is a biopharmaceutical company dedicated to addressing global challenges in infectious diseases and biodefense. The company focuses on innovative drug development programs aimed at meeting unmet patient needs across a variety of infectious diseases. Their product pipeline includes a novel oral suspension for serious infections,... Read More
